Warts, molluscum and things that go bump on the skin: A practical guide

Archives of Disease in Childhood: Education and Practice Edition

Volumn 92, Issue 4, 2007, Pages

  Lio, Peter ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CANTHARIDIN; CIMETIDINE; CODEINE; IMIQUIMOD; LACTIC ACID; LIDOCAINE; LIQUID NITROGEN; MIDAZOLAM; PARACETAMOL; POTASSIUM HYDROXIDE; SALICYLIC ACID; SQUARIC ACID; ZINC SULFATE;

ARTICLE; BALNEOTHERAPY; BLISTER; CHILD CARE; CHILD HEALTH; CLINICAL FEATURE; CLINICAL TRIAL; CRYOTHERAPY; CURETTAGE; DIFFERENTIAL DIAGNOSIS; EPILUMINESCENCE MICROSCOPY; ERYTHEMA; HUMAN; HYPNOSIS; IMMUNOTHERAPY; LOW LEVEL LASER THERAPY; MOLLUSCIPOXVIRUS; MOLLUSCUM CONTAGIOSUM; MONOTHERAPY; PAIN; PRIORITY JOURNAL; RECURRENCE RISK; UNSPECIFIED SIDE EFFECT; VERRUCA PLANA JUVENILIS; VERRUCA PLANTARIS; VERRUCA VULGARIS; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTI-INFECTIVE AGENTS; CANTHARIDIN; CRYOTHERAPY; DIAGNOSIS, DIFFERENTIAL; DISEASE TRANSMISSION, HORIZONTAL; HUMANS; HYPERTHERMIA, INDUCED; IRRITANTS; MOLLUSCUM CONTAGIOSUM; RECURRENCE; RISK FACTORS; SALICYLIC ACID; SKIN DISEASES; TREATMENT OUTCOME; WARTS;

EID: 34547760875     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/adc.2007.122317     Document Type: Article

References (48)

1. Shelley WB, Shelley ED. Advanced dermatologic therapy. Philadelphia: Saunders, 1987.
2. Bunney MH, Benton C, Cubie HA. Viral warts: biology and treatment, Second edition. Oxford, UK: Oxford University Press, 1992.
3. Champion RH, Rook A, Wilkinson DS, et al. Rook/Wilkinson/Ebling textbook of dermatology, Sixth edition. Oxford, UK: Blackwell Science, 1998.
4. Hazard K, Karlsson A, Andersson K, et al. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 2007;127:116-19.
5. Massing AM, Epstein WL. Natural history of warts. A two-year study. Arch Dermatol 1963;87:306-10.
6. Ghura HS, Camp RD. Scarring molluscum contagiosum in patients with severe atopic dermatitis: report of two cases. Br J Dermatol 2001;144:1094-5.
7. Braue A, Ross G, Varigos G, et al. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol 2005;22:287-94.
8. Dohil MA, Lin P, Lee J, et al. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol 2006;54:47-54.
9. Binkley GW, Deoreo GA, Johnson HH Jr. An eczematous reaction associated with molluscum contagiosum. AMA Arch Derm 1956;74:344- 8.
10. Shelley WB, Shelley ED. Advanced dermatologic diagnosis. Philadelphia, USA: Saunders, 1992.
11. de Souza JA. Molluscum or a mimic? Am J Med 2006;119:927-9.
12. Shelley WB, Burmeister V. Office diagnosis of molluscum contagiosum by light microscopic demonstration of virions. Cutis 1985;36:465-6.
13. Gibbs S, Harvey I. Topical treatments for cutaneous warts. Cochrane Database Syst Rev 2006;3:CD001781.
14. van der Wouden JC, Menke J, Gajadin S, et al. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev 2006;2:CD004767.
15. Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ 2002;325:461.
16. Gibbs S, Harvey I, Sterling JC, et al. Local treatments for cutaneous warts. Cochrane Database Syst Rev 2003;3:CD001781.
17. Kuykendall-Ivy TD, Johnson SM. Evidence-based review of management of nongenital cutaneous warts. Cutis 2003;71:213-22.
18. Lipke MM. An armamentarium of wart treatments. Clin Med Res 2006;4:273-93.
19. Abernethy H, Cho C, DeLanoy A, et al. Clinical inquiries. What nonpharmacological treatments are effective against common nongenital warts? J Fam Pract 2006;55:801-2.
20. Ebell M. Effective topical treatments for nongenital warts. Am Fam Physician 2007;75:1001-2.
21. Lewis TG, Nydorf ED. Intralesional bleomycin for warts: a review, J Drugs Dermatol 2006;5:499-504.
22. Yamamoto T. Bleomycin and the skin. Br J Dermatol 2006;155:869-75.
23. Gibbs S. Topical immunotherapy with contact sensitizers for viral warts. Br J Dermatol 2002;146:705.
24. Gibbs S. Zinc sulphate for viral warts. Br J Dermatol 2003;148:1082-3.
25. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 2002;146:423-31.
26. Phoenix SL. Psychotherapeutic intervention for numerous and large viral warts with adjunctive hypnosis: a case study. Am J Clin Hypn 2007;49:211-18.
27. Meineke V, Reichrath J, Reinhold U, et al. Verrucae vulgares in children: successful simulated X-ray treatment (a suggestion-based therapy). Dermatology 2002;204:287-9.
28. Sinclair-Gieben AH, Chalmers D. Evaluation of treatment of warts by hypnosis. Lancet 1959;2:480-2.
29. Park HS, Kim JW, Jang SJ, et al. Pulsed dye laser therapy for pediatric warts. Pediatr Dermatol 2007;24:177-81.
30. Vargas H, Hove CR, Dupree ML, et al. The treatment of facial verrucae with the pulsed dye laser. Laryngoscope 2002;112:1573-6.
31. Ross BS, Levine VJ, Nehal K, et al. Pulsed dye laser treatment of warts: an update. Dermatol Surg 1999;25(5):377-80.
32. Williams HC. Evidence-based dermatology. London, UK: BMJ Books, 2003.
33. Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate. Int J Toxicol 2003;22(Suppl 3):1-108.
34. El-Tonsy MH, Anbar TE, El-Domyati M, et al. Density of viral particles in pre and post Nd: YAG laser hyperthermia therapy and cryotherapy in plantar warts. Int J Dermatol 1999;38:393-8.
35. Connolly M, Bazmi K, O'Connell M, et al. Cryotherapy of viral warts: a sustained 10-s freeze is more effective than the traditional method. Br J Dermatol 2001;145:554-7.
36. Keogh-Brown MR, Fordham RJ, Thomas KS, et al. To freeze or not to freeze: a cost-effectiveness analysis of wart treatment. Br J Dermatol 2007;156:687-92.
37. Vender RB, Goldberg O. Innovative uses of imiquimod. J Drugs Dermatol 2005;4:58-63.
38. Bacelieri R, Johnson SM. Cutaneous warts: an evidence-based approach to therapy. Am Fam Physician 2005;72:647-52.
39. Kim MB, Ko HC, Jang HS, et al. Treatment of flat warts with 5% imiquimod cream. J Eur Acad Dermatol Venereol 2006;20:1349-50.
40. Harwood CA, Perrett CM, Brown VL, et al. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals. Br J Dermatol 2005;152:122-9.
41. Smolinski KN, Yan AC. How and when to treat molluscum contagiosum and warts in children. Pediatr Ann 2005;34:211-21.
42. Guirguis-Blake J. Interventions for molluscum contagiosum. Am Fam Physician 2006;74:1504.
43. Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol 2006;23:574-9.
44. Sirverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol 2000;43:503-7.
45. Moed L, Shwayder TA, Chang MW. Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol 2001;137:1357-60.
46. Bertaux B, Prost C, Heslan M, et al. Cantharide acantholysis: endogenous protease activation leading to desmosomal plaque dissolution. Br J Dermatol 1988;118:157-65.
47. Arican O. Topical treatment of molluscum contagiosum with imiquimod 5% cream in Turkish children. Pediatr Int 2006;48:403-5.
48. Campanelli A, Krischer J, Saurat JH. Topical application of imiquimod and associated fever in children. J Am Acad Dermatol 2005;52:e1.